Marc Martinell

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia

Tamara Maes, Cristina Mascaró, Iñigo Tirapu et al. · Cancer Cell · 2018 · 326 citations · Full text

Hematological Malignancy, Medicine, Drug Discovery +8

DNA Interaction and Dual Topoisomerase I and II Inhibition Properties of the Anti-Tumor Drug Prodigiosin

Beatriz Montaner, Wilmar Castillo, Marc Martinell et al. · Toxicological Sciences · 2005 · 89 citations · Full text

The ‘paradigm of extremes’: extremely low genetic diversity in an extremely narrow endemic species, Coristospermum huteri (Umbelliferae)

Jordi López‐Pujol, Marc Martinell, Sergi Massó et al. · Plant Systematics and Evolution · 2012 · 62 citations

Biology, Genetic Diversity, Biodiversity +11

Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations

Tamara Maes, Cristina Mascaró, David Rotllant et al. · PLoS ONE · 2020 · 59 citations · Full text

Neurotransmitter, Neurotransmission, Epigenetics +22

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia

Laura Rodríguez‐Pascau, Elena Britti, Pablo Calap-Quintana et al. · Neurobiology of Disease · 2020 · 57 citations · Full text